CMS Coverage Email Updates

Monoclonal Antibodies Directed Against Amyloid for the Treatment of Alzheimer’s Disease       Posted final NCD and decision memo https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo.aspx?proposed=N&ncaid=305

Centers for Medicare & Medicaid Services (CMS) has sent this update. To contact Centers for Medicare & Medicaid Services (CMS) go to our contact us page.